Cancer News and Research

Latest Cancer News and Research

Rethink praises Ontario's decision to provide breast cancer patients with access to Herceptin

Today, Rethink Breast Cancer (Rethink) applauds the Ontario government's decision to provide breast cancer patients with tumours less than or equal to 1 cm access to the revolutionary drug Herceptin under the new Evidence Building Program.

13 May 2011

TFAH applauds HHS for new strategic approach to prevent viral hepatitis

The Trust for America's Health applauds the U.S. Department of Health and Human Services for unveiling a new strategic approach to dealing with the silent epidemic of viral hepatitis today.

13 May 2011

New circumcision treatment can reduce HIV

Promising study results published in the May issue of JAIDS show that a novel medical device has the potential to revolutionize how male circumcision services are offered in countries hardest hit by the HIV epidemic.

13 May 2011

Scientists discover enzyme that controls K-Ras gene responsible for lung cancer growth

Cancer Research UK scientists have discovered that an enzyme called C-Raf controls a hugely important gene responsible for the development of lung cancer, according to research published in Cancer Discovery.

13 May 2011

Groundbreaking cancer treatment studies to be unveiled at AAPS National Biotechnology Conference

Cancer studies from Mercer University headline groundbreaking research that will be unveiled at the American Association of Pharmaceutical Scientists' (AAPS) National Biotechnology Conference (NBC).

13 May 2011

Majority of Americans support ban on menthol cigarettes

According to a new study released online today, a majority of Americans, including most African Americans, stand together in support of banning menthol in cigarettes just as other cigarette flavorings have now been banned by the FDA.

13 May 2011

Researchers identify miRNA in blood serum of lung cancer patients

Researchers have identified characteristic patterns of molecules called microRNA in the blood of people with lung cancer that might reveal both the presence and aggressiveness of the disease, and perhaps who is at risk of developing it.

13 May 2011

ACS, PGi celebrate 10 years of partnership on key cancer initiatives

Atlanta-based PGi, a global leader in real-time, meeting solutions, and the American Cancer Society are celebrating 10 years of working together on key Society initiatives, including the ACS signature cancer fundraising event, Relay for Life.

13 May 2011

Study: OVA1 blood test can accurately predict ovarian cancer in women with pelvic masses

A study published online ahead of print in the June 2011 edition of Obstetrics & Gynecology demonstrated that American College of Obstetrics and Gynecology guidelines for determining the likelihood that an ovarian mass is cancerous prior to surgery would accurately identify more women with ovarian cancer if the OVA1 blood test were used in place of the currently recommended CA 125 blood test.

From Quest Diagnostics 13 May 2011

ACR to honor UCLA cancer researcher with Gold Medal for radiology work

Dr. Lawrence W. Bassett, a nationally renowned expert with more than 35 years experience in breast imaging, has been chosen to receive the Gold Medal by the American College of Radiology, the organization's highest honor given for distinguished and extraordinary service in the field of radiology.

13 May 2011

Coffee provides protections from a type of breast cancer: Study

For the study they compared coffee consumption in postmenopausal women with breast cancer and women of the same age without cancer, they found those who drank five or more cups of java a day showed a 0.43 times lower risk of estrogen-receptor negative cancers. Around one in four women diagnosed with breast cancer will have estrogen-receptor negative breast cancer, which is often resilient to drug treatment and requires intensive chemotherapy.

12 May 2011

Nearly one third of the miners on a synthetic form of cannabis

New research has revealed that a synthetic form of cannabis is being consumed and has shown up in one in ten West Australian mine workers’ urine samples. The state's ChemCentre provides forensic testing for police and the State Coroner. They have been given the contract on an increasing basis by private companies in mining regions to test their workers for the substance, known as Kronic.

12 May 2011

Researchers help explain why smart drugs are not effective in some cancer patients

Some of the most effective and expensive cancer drugs, dubbed "smart drugs" for their ability to stop tumors by targeting key drivers of cancer cell growth, are not effective in some patients. In two related studies, Yale School of Medicine researchers examined one such driver, the EGF receptor, and found that a decoy receptor might be limiting the amount of drug that gets to the intended target.

12 May 2011

Chemical engineer builds working models of human tissues for disease research

Shelly Peyton, a chemical engineer at the University of Massachusetts Amherst, is building working models of human bone, breast, liver and artery tissues to see how cells behave when they are affected by a disease such as cancer.

12 May 2011

German doctors among first to treat ischemic stroke patients with new blood clot retrieval device

Doctors in Germany are among the first to treat ischemic stroke patients outside the United States with the REVIVE SE, a new self-expanding blood clot retrieval and removal device designed to remove blood clots and restore blood flow to the brain in patients having a stroke.

12 May 2011

Trillium raises $1 million to advance TTI-1612 into clinical trials for interstitial cystitis treatment

Trillium Therapeutics Inc., a privately-held biopharmaceutical company, announced today that it has raised $1 million from a new undisclosed investor. The funds will be used to advance its lead program, TTI-1612, into clinical trials for the treatment of interstitial cystitis, also known as bladder pain syndrome. The first trial is projected to start in the second half of this year.

12 May 2011

New organocatalyst now available for drug development industry

A new "organocatalyst" developed at Oregon State University is now available for commercial use. Produced by an Albany, Ore., pharmaceutical company, it should make new drug development around the world less costly, more efficient and more environmentally friendly.

12 May 2011

Swedish adds new virtual reality training simulator to help surgeons practice on robotic-assisted system

As one of the first medical centers in the Northwest to perform robotic-assisted surgery, Swedish is home to the fastest growing, most comprehensive and experienced robotic-assisted surgical program in the region. Swedish established the multidisciplinary, robotic-assisted surgical program in 2005 and has since performed more than 3,400 robotic-assisted surgeries -- more than any other program in the region.

12 May 2011

Biocept's paper describes identification of different CTC phenotypes in cancer patients

Biocept, Inc., a privately-held laboratory testing company focused on the detection, enumeration and analysis of circulating tumor cells (CTCs) in cancer patients, today announced the publication of a paper describing the identification of different CTC phenotypes using its proprietary Cell Enrichment and Extraction platform.

12 May 2011

Health Canada approves EMEND IV formulation to prevent chemotherapy-induced nausea, vomiting

Today Merck announced that Health Canada has approved the new intravenous formulation of EMEND IV. Used in combination with a 5-HT3 antagonist class of antiemetics and dexamethasone, fosaprepitant dimeglumine is indicated for the prevention of acute and delayed nausea and vomiting due to highly emetogenic cancer chemotherapy.

12 May 2011

Cancer News and Research

Latest Cancer News and Research

Rethink praises Ontario's decision to provide breast cancer patients with access to Herceptin

TFAH applauds HHS for new strategic approach to prevent viral hepatitis

New circumcision treatment can reduce HIV

Scientists discover enzyme that controls K-Ras gene responsible for lung cancer growth

Groundbreaking cancer treatment studies to be unveiled at AAPS National Biotechnology Conference

Majority of Americans support ban on menthol cigarettes

Researchers identify miRNA in blood serum of lung cancer patients

ACS, PGi celebrate 10 years of partnership on key cancer initiatives

Study: OVA1 blood test can accurately predict ovarian cancer in women with pelvic masses

ACR to honor UCLA cancer researcher with Gold Medal for radiology work

Coffee provides protections from a type of breast cancer: Study

Nearly one third of the miners on a synthetic form of cannabis

Researchers help explain why smart drugs are not effective in some cancer patients

Chemical engineer builds working models of human tissues for disease research

German doctors among first to treat ischemic stroke patients with new blood clot retrieval device

Trillium raises $1 million to advance TTI-1612 into clinical trials for interstitial cystitis treatment

New organocatalyst now available for drug development industry

Swedish adds new virtual reality training simulator to help surgeons practice on robotic-assisted system

Biocept's paper describes identification of different CTC phenotypes in cancer patients

Health Canada approves EMEND IV formulation to prevent chemotherapy-induced nausea, vomiting

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in